PATENT CLAIM ANALYSIS

Application Number: 15971127
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-08
Patent Classification: ["424", "133100"]

Abstract:
The invention provides anti-IFNAR1 antibodies with reduced affinity for Fc receptors and/or ligands and methods of making and using such antibodies.

Claim (Index 53):
A crystal comprising a human IgG Fc region, wherein the human IgG Fc region comprises at least one amino acid substitution selected from the group consisting of L234F, L235E, and P331S, as numbered by the EU index as set forth in Kabat and wherein said fragment exhibits reduced affinity for at least one Fc ligand compared to an unmodified Fc region.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 93.0
- Lexical Diversity: 1.1
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15711197', '13431489', '13483280', '11203251', '15714585']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6986811859922957
- 35 USC 102 Novelty (BERT): 0.6804051786736427
- Combined Prediction Score: 0.6968535852604304
- Mean Citation Score: 445.23375
- Max Citation Score: 850.0428
- Similarity Product: 655.2701373491765

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test